NEW YORK, June 21 - After building its proteomics platform with the help of IBM, Agilent, and other technology providers, MDS Proteomics is ready to start partnering with pharmaceutical companies who will pay MDS Proteomics for its services, chief business officer Caroline Popper told GenomeWeb.

"Our partnering strategy was to make the platform robust," she said. "And now we're ready to put in the product relationships, and we're heavily in negotiations with major pharmaceutical companies."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.